Page 54 - Malaria News Today

All you need to know about the world’s second malaria vaccine

The Sahel region is grappling with an outbreak of the deadly mosquito-borne disease.

Rising temperatures, fluctuations in precipitation patterns and extreme weather events are all affecting the life cycles and habitats of mosquitoes that...

Plasmodium vivax is the most widespread human malaria-causing pathogen with 2.5 billion people living at risk in Africa, South America, Oceania, and Asia.

The number of malaria cases has been rising sharply in Korea this year, reaching the highest level in 12 years, health authorities said Sunday.

Johns Hopkins researchers looking to develop a long-acting, injectable malaria preventive using atovaquone have shown in a new study that resistance may not be the challenge scientists thought it was, particularly when using atovaquone as a malaria preventive.

Kwara Governor’s wife, Amb. Olufolake Abdulrazaq, has pledged to use her office to ensure that children in the state no longer die of malaria.

Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. Our episode is live! Episode Description We begin this episode by discussing our article of the week from the New England

Malaria is a unique mosquito-borne disease caused by a parasite and is transmitted through female anopheles mosquitoes often found in tropical and subtropical areas such as in Africa south of the Sahara and parts of Oceania such as Papua New Guinea. Anopheles mosquitoes are not found in Hawai‘i. Malaria is not spread from person to person and is not sexually transmitted. The incubation period is typically from seven to 30 days.

India’s pharmaceutical industry aims to scale up vaccine manufacturing to satisfy the demands of more African nations with high malaria burdens and thereby support international efforts to save lives